Entrada Therapeutics (TRDA) Technical Analysis

As of 2026-07-22, TRDA last traded at 6.15 USD (-4.80% on the day) and is in a downtrend on the daily timeframe — price below falling 50-DMA, 50-DMA below 200-DMA. Nearest levels: 6.09 USD support below, 6.9 USD resistance above. 14-day RSI is 27.2 (oversold).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is TRDA in an uptrend or downtrend?

Entrada Therapeutics is in a downtrend — price below falling 50-DMA, 50-DMA below 200-DMA.

Last close6.15 USD (-4.80%)
20-day average7.133 USD
50-day average6.823 USD
200-day average9.632 USD

Key support and resistance levels for TRDA

Derived from swing pivots over the last 200 sessions:

LevelTypeStrengthTouches
6.9 USDResistanceMinor1
7.14 USDResistanceModerate2
7.54 USDResistanceMinor1
LevelTypeStrengthTouches
6.09 USDSupportMinor1
5.745 USDSupportModerate2
5.63 USDSupportMinor1

TRDA 52-week range, momentum and volatility

52-week high16.45 USD (62.6% below)
52-week low4.93 USD (24.7% above)
14-day RSI27.2 (Oversold)
14-day ATR0.466 USD (7.57% of price, High volatility)

Related research pages

Frequently asked questions

Is Entrada Therapeutics (TRDA) in an uptrend or downtrend?

As of 2026-07-22, TRDA is in a downtrend on the daily timeframe — price below falling 50-DMA, 50-DMA below 200-DMA. Last close 6.15 USD vs 50-day average 6.823 USD and 200-day average 9.632 USD.

What are the key support and resistance levels for TRDA?

Nearest support is around 6.09 USD (minor, 1 touch). Nearest resistance is around 6.9 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is TRDA's 52-week high and low?

Over the last 52 weeks, TRDA traded between 4.93 USD and 16.45 USD. It is currently 62.6% below its 52-week high.

Is TRDA overbought or oversold?

The 14-day RSI is 27.2 — in oversold territory (<30). Momentum reads as oversold.

How volatile is TRDA?

Its 14-day Average True Range is 0.466 (7.57% of price) — high volatility relative to price.